Following a 24 h treatment with 200 μg/mL HA and sHA in MCF-7 and MDA-MB-231 cells, no significant differences were observed in the expression (mRNA and protein) levels of CD44, except a slight decrease seen upon treatments with sHA, in both breast cancer cell line tested (Figure 5C–F). This evidence concerns the gene CD44 and breast carcinoma.